Shanghai Rightongene Biotechnology Co.Ltd(688217) independent directors
Special description and independent opinions on external guarantee in 2021
As an independent director of Shanghai Rightongene Biotechnology Co.Ltd(688217) (hereinafter referred to as “the company”), we checked the external guarantee of the company in 2021 with a rigorous, realistic and prudent attitude, and made the following special instructions and independent opinions in accordance with the relevant laws and regulations such as the guidelines for the supervision of listed companies No. 8 – regulatory requirements for capital transactions and external guarantee of listed companies and the articles of association:
(I) special description
1. In accordance with relevant laws and regulations and the relevant provisions of the CSRC, the company has defined the authority and deliberation procedures of the general meeting of shareholders and the board of directors for approving external guarantees in the articles of association.
2. During the reporting period, the company did not have any form of external guarantee, nor did it have any external guarantee that occurred in the previous period but lasted until the reporting period.
(II) independent opinions
The company strictly abides by the provisions of laws and regulations and the articles of association on guarantee matters, strictly controls the guarantee risk, does not provide any guarantee to the controlling shareholders, actual controllers and their related parties, and does not have any illegal guarantee behavior or damage the interests of the company and all shareholders.
Shanghai Rightongene Biotechnology Co.Ltd(688217) independent directors: Yuan Xuewei, Xu Weijian, Zhao Guiying April 18, 2022
